Human Pharmacogenomics SNP Detection Kit

Human Pharmacogenomics SNP Detection Kit Human Pharmacogenomics SNP Detection Kit Next Generation Sequencing Only for scientific research use in China It is reported that adverse drug reactions accounted for the fourth to sixth major cause of global death.In China, there are 2.5 million people who were hospitalized because of adverse drug reactions per year, 200,000 people died of adverse drug reactions per year.In the United States, 2 million people who were hospitalized because of adverse drug reactions per year, more than 100,000 people died of adverse drug reactions per year. Change in drug metabolicenzymes and pharmacological target genes characteristics can bring about individual differences in drug responsiveness (including drug efficacy and adverse drug reaction) through influencing the concentration of the drug invivo , and the sensitivity of the target tissue to the drug. This kit detects the SNP mutations of 22 pharmacogenomics related genes, which can guide the clinical selection of appropriate drugs and dosage for specific patients, to achieve individualized medication, so as to improve the effectiveness and safety of drug treatment and prevent serious adverse drug reactions occur.